| Institution: | 1. Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas;2. Department of Investigational Cancer Therapeutics (Phase I Program), The University of Texas MD Anderson Cancer Center, Houston, Texas;3. Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas;4. Apocell Molecular Profiling and Diagnostics, Houston, Texas;5. Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, Maryland;6. Division of Hematology and Oncology, Moores Cancer Center, University of California at San Diego, San Diego, California |
